,address1,city,state,zip,country,phone,website,industry,industryDisp,sector,sectorDisp,longBusinessSummary,fullTimeEmployees,companyOfficers,auditRisk,boardRisk,compensationRisk,shareHolderRightsRisk,overallRisk,governanceEpochDate,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,forwardEps,pegRatio,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,uuid,messageBoardId,gmtOffSetMilliseconds,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Mr. Richard A. Gonzalez', 'age': 68, 'title': 'Chairman & CEO', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 6948244, 'exercisedValue': 0, 'unexercisedValue': 43528872}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
1,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Mr. Robert A. Michael', 'age': 52, 'title': 'Pres & COO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 3998042, 'exercisedValue': 0, 'unexercisedValue': 13150419}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
2,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Mr. Scott T. Reents', 'age': 54, 'title': 'Exec. VP & CFO', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 2972736, 'exercisedValue': 0, 'unexercisedValue': 5172329}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
3,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Dr. Azita  Saleki-Gerhardt Ph.D.', 'age': 59, 'title': 'Exec. VP & COO', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 2576755, 'exercisedValue': 0, 'unexercisedValue': 28534760}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
4,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Mr. Jeffrey Ryan Stewart', 'age': 53, 'title': 'Exec. VP & Chief Commercial Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 2983231, 'exercisedValue': 2777988, 'unexercisedValue': 10864175}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
5,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Dr. Thomas J. Hudson M.D.', 'age': 60, 'title': 'Sr. VP of R&D and Chief Scientific Officer', 'yearBorn': 1962, 'exercisedValue': 0, 'unexercisedValue': 0}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
6,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Ms. Elizabeth  Shea', 'title': 'VP of Investor Relations', 'exercisedValue': 0, 'unexercisedValue': 0}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
7,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Ms. Tracie  Haas', 'title': 'Sr. VP of Corp. Responsibility, Brand & Communications', 'exercisedValue': 0, 'unexercisedValue': 0}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
8,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Mr. Timothy J. Richmond', 'age': 56, 'title': 'Exec. VP & Chief HR Officer', 'yearBorn': 1966, 'fiscalYear': 2013, 'exercisedValue': 0, 'unexercisedValue': 0}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
9,1 North Waukegan Road,North Chicago,IL,60064-6400,United States,847 932 7900,https://www.abbvie.com,Drug Manufacturers—General,Drug Manufacturers—General,Healthcare,Healthcare,"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; and California Institute for Biomedical Research (Calibr). The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.",50000,"{'maxAge': 1, 'name': 'Dr. Nicholas R. Donoghoe M.D.', 'age': 41, 'title': 'Exec. VP and Chief Bus. & Strategy Officer', 'yearBorn': 1981, 'exercisedValue': 0, 'unexercisedValue': 0}",9,7,7,9,9,1693526400,1672444800,86400,2,153.64,152.78,151.93,154.7,153.64,152.78,151.93,154.7,5.92,0.038900003,1697068800,1.1893001,4.49,0.547026,31.364948,13.754067,8593072,8593072,5096245,4854360,4854360,152.23,152.39,2900,800,268499402752,130.96,168.11,4.792664,146.1692,150.1716,5.85,0.03807602,USD,321157890048,0.15502,1762275557,1765049984,12454309,11436751,1690761600,1693440000,0.0070999996,0.00131,0.71415,3.02,0.0070999996,1765049984,7.29,20.86694,1672444800,1703980800,1688083200,1.19,8634999808,4.85,11.06,-3.36,5.733,11.0,0.06631148,0.14113986,1.48,1689206400,NYQ,EQUITY,ABBV,ABBV,AbbVie Inc.,AbbVie Inc.,1357137000,America/New_York,EDT,73238d42-cdcc-3f92-8141-dd675addae10,finmb_141885706,-14400000,152.12,205.0,135.0,169.42,167.5,2.4,buy,24,8766000128,4.966,29195999232,61392998400,0.628,0.895,56022999040,475.988,31.651,0.09175,0.63017,41527000000,23683999744,25542000640,1.234,-0.049,0.70473,0.52114,0.36498,USD,6.0373
